Answer
Zeposia (ozanimod hydrochloride) is indicated for adults with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
Sources for this answer
- Zeposia 0.23 mg, 0.46 and 0.92 mg hard capsulesBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.1 Therapeutic Indications · Version 10Document updated
Sources checked